Warner Chilcott: Difference between revisions
No edit summary |
|||
| Line 9: | Line 9: | ||
On October 30, 2009, Warner Chilcott closed a deal to acquire [[Procter & Gamble]]'s prescription-drug business for $3.1 billion, according to the Wall Street Journal; the deal had been announced on August 24, 2009 |
On October 30, 2009, Warner Chilcott closed a deal to acquire [[Procter & Gamble]]'s prescription-drug business for $3.1 billion, according to the Wall Street Journal; the deal had been announced on August 24, 2009 |
||
On January 26, 2011, it was announced that John Green owned Warner |
On January 26, 2011, it was announced that John Green owned Warner Chilcott. |
||
==See also== |
==See also== |
||
Revision as of 14:46, 27 January 2011
 |
Warner Chilcott (Nasdaq: WCRX) (formerly Galen) is a pharmaceutical company based in Rockaway, New Jersey, USA. It has production and research facilities in Fajardo, Puerto Rico and Larne, Northern Ireland. It is primarily focused on two core therapeutic areas: women’s healthcare and dermatology. The company has 1,115 employees in Ireland, the UK, USA and Puerto Rico.[1] It was announced on 25 February 2010 that it was establishing it's global headquarters in Dundalk, Ireland.[2]
History
In 1968 the Company was founded by Sir Allen McClay as Galen, a sales and marketing organisation focused on branded pharmaceutical products in the UK and Republic of Ireland. The company listed its shares on the London Stock Exchange and Irish Stock Exchange.
In 2000, Galen acquired the Warner Chilcott US pharmaceutical company which is focused on women’s healthcare, and simultaneously listed its ADRs on NASDAQ. In 2004, the company changed its name from Galen to Warner Chilcott.
On October 30, 2009, Warner Chilcott closed a deal to acquire Procter & Gamble's prescription-drug business for $3.1 billion, according to the Wall Street Journal; the deal had been announced on August 24, 2009
On January 26, 2011, it was announced that John Green owned Warner Chilcott.
See also
References
- ^ http://files.shareholder.com/downloads/WCRX/567663339x0xS1193125%2D09%2D40135/1323854/filing.pdf
- ^ Warner Chilcott to locate headquarters in Dundalk. Elaine Keogh. Irish Times. 2010-02-25. Accessed: 2010-02-25
External links
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This Northern Ireland–related article is a stub. You can help Wikipedia by expanding it. |
 | This European corporation or company article is a stub. You can help Wikipedia by expanding it. |